Dermatology clinical trials recruiting in Pennsylvania

39 recruiting dermatology trials match in Pennsylvania. Showing 20.

• Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic ArthritisRecruiting

  Phase 2 · AbbVie · Duncansville, Pennsylvania

• A Study Evaluating BFB759 in Moderate to Severe Hidradenitis SuppurativaRecruiting

  Phase 2 / Phase 3 · Bluefin Biomedicine, Inc. · Pittsburgh, Pennsylvania

• A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic ArthritisRecruiting

  Phase 3 · Janssen Research & Development, LLC · Duncansville, Pennsylvania

• Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Recruiting

  Phase 2 · Merck Sharp & Dohme LLC · Duncansville, Pennsylvania

• A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic DermatitisRecruiting

  Phase 2 · Janssen Research & Development, LLC · São Paulo

• A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsRecruiting

  Phase 1 · UCB Biopharma SRL · Duncansville, Pennsylvania

• A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic DermatitisRecruiting

  Phase 2 · UCB Biopharma SRL · Philadelphia, Pennsylvania

• A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic DermatitisRecruiting

  Phase 2 · Hoffmann-La Roche · Camp Hill, Pennsylvania

• A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque PsoriasisRecruiting

  Phase 2 · InventisBio Co., Ltd · Birmingham, Alabama

• The Impact of Botox on Neuroimmune Interactions in Atopic DermatitisRecruiting

  Phase 1 · Daniel Kaplan · Pittsburgh, Pennsylvania

• A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic ArthritisRecruiting

  Phase 4 · CARE ARTHRITIS LTD. · Philadelphia, Pennsylvania

• A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic ArthritisRecruiting

  Phase 2 · Janssen Research & Development, LLC · Philadelphia, Pennsylvania

• Guselkumab vs Golimumab in PsA TNF Inadequate Responder PatientsRecruiting

  Phase 3 · University of Pennsylvania · Philadelphia, Pennsylvania

• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruiting

  Phase 1 · National Cancer Institute (NCI) · Pittsburgh, Pennsylvania

• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 2 · Apollo Therapeutics Ltd · Camp Hill, Pennsylvania

• A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar PustulosisRecruiting

  Phase 2 · LEO Pharma · Philadelphia, Pennsylvania

• FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and PatientsRecruiting

  Phase 1 · Pfizer · Anaheim, California

• Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe AcneRecruiting

  Phase 1 / Phase 2 · Sanofi Pasteur, a Sanofi Company · Camp Hill, Pennsylvania

• A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to DupilumabRecruiting

  Phase 3 · AbbVie · Philadelphia, Pennsylvania

• A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic DermatitisRecruiting

  Phase 1 · Brexogen Inc. · Camp Hill, Pennsylvania

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.